Torthaí cuardaigh - "lung cancer"

Clinical outcomes of gemcitabine-loaded callispheres drug-eluting beads for patients with advanced and inoperable lung cancer: A case series study de réir Yonghua Bi, Bo Zhang, Jianzhuang Ren, Xinwei Han, Wenze Wu

Connect to this object online.

Chemotherapy related changes in cfDNA levels in squamous non-small cell lung cancer: correlation with symptom scores and radiological responses de réir Nithiyanandan Ravi, Parul Gupta, Amanjit Bal, Kuruswamy Thurai Prasad, Mandeep Garg, Rakesh Kapoor, Navneet Singh

Connect to this object online.

Cost-effectiveness analysis of tislelizumab, nivolumab and docetaxel as second- and third-line for advanced or metastatic non-small cell lung cancer in China de réir Dongchu Zhou, Xia Luo, Zhen Zhou, Xiaohui Zeng, Xiaomin Wan, Chongqing Tan, Qiao Liu

Connect to this object online.

Comparative analysis of using atezolizumab vs. durvalumab in combination with platinum-containing chemotherapy in adult patients with advanced small cell lung cancer de réir I. S. Krysanov, E. V. Makarova, V. Yu. Ermakova

Connect to this object online.

Evaluation of an online training tool for scoring programmed cell death ligand-1 (PD-L1) diagnostic tests for lung cancer de réir Bharat Jasani, Gudrun Bänfer, Rebecca Fish, Wim Waelput, Yves Sucaet, Craig Barker, Jessica L. Whiteley, Jill Walker, Rudy Hovelinck, Rolf Diezko

Connect to this object online.

Comment on "Prediction of the 1-Year Risk of Incident Lung Cancer: Prospective Study Using Electronic Health Records from the State of Maine" de réir Rahmani, Jamal, Karimi, Roya, Khani, Yousef, Sabour, Siamak

Connect to this object online.

Usefulness of BRAF VE1 immunohistochemistry in non-small cell lung cancers: a multi-institutional study by 15 pathologists in Korea de réir Sunhee Chang, Yoon-La Choi, Hyo Sup Shim, Geon Kook Lee, Seung Yeon Ha, Korean Cardiopulmonary Pathology Study Group

Connect to this object online.

Effectiveness and Cost-Effectiveness Profile of Second-Line Treatments with Nivolumab, Pembrolizumab and Atezolizumab in Patients with Advanced Non-Small Cell Lung Cancer de réir Matteo Franchi, Giacomo Pellegrini, Giovanni Corrao

Connect to this object online.

Application value of the automated machine learning model based on modified CT index combined with serological indices in the early prediction of lung cancer de réir Leyuan Meng, Ping Zhu, Ping Zhu, Kaijian Xia, Kaijian Xia

Connect to this object online.

Targeting AKT/mTOR and Bcl-2 for Autophagic and Apoptosis Cell Death in Lung Cancer: Novel Activity of a Polyphenol Compound de réir Sucharat Tungsukruthai, Onrapak Reamtong, Sittiruk Roytrakul, Suchada Sukrong, Chanida Vinayanwattikun, Pithi Chanvorachote

Connect to this object online.

Association between H19 SNP rs217727 and lung cancer risk in a Chinese population: a case control study de réir Lingling Li, Genyan Guo, Haibo Zhang, Baosen Zhou, Lu Bai, He Chen, Yuxia Zhao, Ying Yan

Connect to this object online.

The Generation of a Lung Cancer Health Factor Distribution Using Patient Graphs Constructed From Electronic Medical Records: Retrospective Study de réir Anjun Chen, Ran Huang, Erman Wu, Ruobing Han, Jian Wen, Qinghua Li, Zhiyong Zhang, Bairong Shen

Connect to this object online.

Exacerbation of symptoms of rheumatoid arthritis in the course of immunotherapy of non-small cell lung cancer - an analysis of medical cases and a review of the literature de réir Julia Bargieł, Justyna Cabaj, Izabela Chmielewska, Magdalena Wójcik-Superczyńska, Janusz Milanowski

Connect to this object online.

Rikkunshito for Preventing Chemotherapy-Induced Nausea and Vomiting in Lung Cancer Patients: Results from 2 Prospective, Randomized Phase 2 Trials de réir Toshiyuki Harada, Toraji Amano, Tomoo Ikari, Kei Takamura, Takahiro Ogi, Toshiaki Fujikane, Yuka Fujita, Kageaki Taima, Hisashi Tanaka, Takaaki Sasaki, Shunsuke Okumura, Shunichi Sugawara, Hiroshi Yokouchi, Noriyuki Yamada, Naoto Morikawa, Hirotoshi Dosaka-Akita, Hiroshi Isobe, Masaharu Nishimura

Connect to this object online.

First-line Immuno-chemotherapy for extensive-stage small-cell lung cancer: A network meta-analysis and cost-effectiveness analysis de réir Youwen Zhu, Kun Liu, Qiuping Yang, Manting Zeng, Manting Zeng, Libo Peng

Connect to this object online.

QSAR study of benzylidene hydrazine benzamides derivatives with in vitro anticancer activity against human lung cancer cell line A459 de réir Galih Satrio Putra, Melanny Ika Sulistyowaty, Tegar Achsendo Yuniarta, Yahmin Yahmin, Sumari Sumari, Charinrat Saechan, Takayasu Yamauchi

Connect to this object online.

Risk Analysis Implications of Dose-Response Thresholds for NLRP3 Inflammasome-Mediated Diseases: Respirable Crystalline Silica and Lung Cancer as an Example de réir Louis Anthony (Tony)

Connect to this object online.

Modes of cell death induced by tetrahydroisoquinoline-based analogs in MDA-MB-231 breast and A549 lung cancer cell lines de réir Nel M, Joubert AM, Dohle W, Potter BVL, Theron AE

Connect to this object online.

Effect of the patient information brochure in communicating the risks associated with crizotinib treatment to patients with non‐small cell lung cancer (NSCLC) in Europe de réir Kui Huang, Terri Madison, Beatrice Wehler, Marcello Tiseo, Keith D. Wilner, Jingping Mo

Connect to this object online.

Combined Treatment of Dendrosomal-Curcumin and Daunorubicin Synergistically Inhibit Cell Proliferation, Migration and Induce Apoptosis in A549 Lung Cancer Cells de réir Seyed Sadegh Eslami, Davod Jafari, Abbas Ghotaslou, Moein Amoupour, Amir Asri Kojabad, Rasool Jafari, Navid Mousazadeh, Parastoo Tarighi, Majid Sadeghizadeh

Connect to this object online.